As per the research report, the size of the global animal parasiticides market was worth USD 9.2 billion in 2020. This value is estimated to be growing at a CAGR of 5.81% and worth USD 12.2 billion by 2025. The rise in the incidences of zoonotic diseases worldwide is majorly surging the growth of the global animal parasiticides market.
In veterinary pharmacies, animal parasiticides are the drugs used to improve the health of livestock. It also prevents some diseases by killing parasites in the body other than bacteria and fungi. The parasites are harmful to the animals in disease-causing and spread the disease quickly to other animals or humans.
Factors such as increasing demand to raise the production rate of the animal healthcare products, growing investments in the veterinary hospitals by government and non-governmental institutes, the rise in the incidences of various health disorders in animals are expected to drive the global animal parasiticides market.
Growing tendency to provide quality treatment for the animals, increasing prevalence for the launch of new products with advanced technology, the rising demand to improve the quality of poultry products, and the rise in zoonotic diseases are other essential causes fuelling the need for animal parasiticides market.
However, fluctuations in the availability of raw materials in manufacturing the final products in the pharmaceutical companies are slowly restraining the market demand. Stringent rules and regulations by the government is another major factor hampering the growth rate of the animal parasiticides market.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Analysed |
By Product Type, Animal Type, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
This research report on the global animal parasiticides market has been segmented and sub-segmented based on the product type, animal type, and region.
Animal Parasiticides Market – By Product Type:
Based on product type, Ectoparasiticides product type is holding the highest shares of the market. The increasing population of livestock is significantly influencing the demand of the market. Ectoparasiticides are very effective in treating the animals' disease with fewer side effects, which are also factors that level the growth of the market. Growing investments in veterinary hospitals by private and public organizations are surging the demand of the market. The rise in the popularity of drugs and vaccines through campaigns and digital advertisements is also likely to outshine the growth rate of the animal parasiticides market.
Animal Parasiticides Market - By Animal Type:
Based on animal type, the Food-producing animal segment is witnessed in leading dominant shares of the market. The increasing consumption rate of meat and poultry products is the primary factor for growing extensively in this segment. Rising concern towards health care among individuals is also boosting up the demand of the market.
Animal Parasiticides Market - By Region:
Geographically, North America is accounted for the highest share of the global animal parasiticides market with the acceptance of advanced technology in launching various products that are highly successful in treating the external or internal parasites in animals.
The Asia Pacific is positioned second in leading dominant shares of the market. Increasing expenditure on animal health care is gearing up the demand for the animal parasiticides market.
Europe has the fastest growth rate from the past few years and is also to maintain the same flow in foreseen years. Growing support from government organizations to prevent the spread of diseases from animals to humans is accelerating the market's growth in this region.
The Middle East and Africa are inclined to have slight variations in the growth rate in the near future with the rise in the awareness over the manufacturing of drugs and vaccines effectively.
KEY MARKET PARTICIPANTS:
Some of the most promising companies operating in the global animal parasiticides market profiled in this report are Sanofi (France), Ceva Sante Animale (France), Virbac (France), Vetoquinol S.A. (France), Eli Lilly and Company (U.S.), Zoetis, Merck and Co., Bayer AG (Germany), Boehringer Ingelheim (Germany), Perrigo Company plc (Ireland).
RECENT HAPPENINGS IN THE GLOBAL ANIMAL PARASITICIDES MARKET:
Acquisition – In August 2019
The second-largest player in the veterinary pharmaceutical market, Elanco, purchased Bayer animal healthcare business, which ensures improving productivity. The acquisition aims to launch various products with advanced technology and to extend the product portfolio.
Agreement – In July 2018
To increase parasiticides' productivity for the companion animals, Bayer animal healthcare has signed an agreement with Mitsui Chemicals Agro. It has improved the efficiency of the products as they maximized the production rate along with quality. Research on examining the cause of various infectious diseases helps this company expand its shares and position in the animal parasiticides market.
Announcement - In November 2015
Zoetis, Inc. announced marketing authorization for Simparica chewable tablets. This medicine is given once a month to treat fleas, ticks, and sarcoptic mange in dogs and show effective outcomes.
Product Launch - In May 2014
An oral ectoparasiticide tablet named Bravecto is launched by Merck Animal Health, a lead player in the animal parasiticides market. This product has significant results for companion animals, which are affected by tick and flea. As oral formulations play an immense role in achieving medication compliance, this tablet addresses the largest demand.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Ectoparasiticides
5.1.3 Endoparasiticide
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Animal Type
5.2.1 Introduction
5.2.2 Food-producing Animals
5.2.3 Companion Animals
5.2.4 Y-o-Y Growth Analysis, By Animal Type
5.2.5 Market Attractiveness Analysis, By Animal Type
5.2.6 Market Share Analysis, By Animal Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Animal Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Animal Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Animal Type
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Sanofi
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Ceva Sante Animale
8.3 Eli Lilly and Company
8.4 Zoetis Inc.
8.5 Merck and Co.
8.6 Bayer AG
8.7 Boehringer Ingelheim
8.8 Perrigo Company Plc
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
